Multinational epidemiological analysis of oral human papillomavirus incidence in 3,137 men

de Martel, C., Georges, D., Bray, F., Ferlay, J. & Clifford, G. M. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob. Health 8, e180–e190 (2020).

Google Scholar 

Chaturvedi, A. K. et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J. Clin. Oncol. 31, 4550–4559 (2013).

PubMed Central  Google Scholar 

Lorenzoni, V. et al. The current burden of oropharyngeal cancer: a global assessment based on GLOBOCAN 2020. Cancer Epidemiol. Biomarkers Prev. 31, 2054–2062 (2022).

Google Scholar 

Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).

Google Scholar 

Tota, J. E. et al. Evolution of the oropharynx cancer epidemic in the United States: moderation of increasing incidence in younger individuals and shift in the burden to older individuals. J. Clin. Oncol. 37, 1538–1546 (2019).

CAS  PubMed Central  Google Scholar 

Guo, F., Chang, M., Scholl, M., McKinnon, B. & Berenson, A. B. Trends in oropharyngeal cancer incidence among adult men and women in the United States From 2001 to 2018. Front. Oncol. 12, 926555 (2022).

PubMed Central  Google Scholar 

Ganly, I. et al. Case control study comparing the HPV genome in patients with oral cavity squamous cell carcinoma to normal patients using metagenomic shotgun sequencing. Sci. Rep. 11, 3867 (2021).

CAS  PubMed Central  Google Scholar 

D’Souza, G. et al. Long-term persistence of oral HPV over 7 years of follow-up. JNCI Cancer Spectr. 4, pkaa047 (2020).

PubMed Central  Google Scholar 

van Aar, F. et al. Twelve-month incidence and clearance of oral HPV infection in HIV-negative and HIV-infected men who have sex with men: the H2M cohort study. BMC Infect. Dis. 14, 668 (2014).

PubMed Central  Google Scholar 

Antonsson, A. et al. Natural history of oral HPV infection: longitudinal analyses in prospective cohorts from Australia. Int. J. Cancer 148, 1964–1972 (2021).

CAS  PubMed  Google Scholar 

Mooij, S. H. et al. Oral human papillomavirus infection in HIV-negative and HIV-infected MSM. AIDS 27, 2117–2128 (2013).

PubMed  Google Scholar 

Giuliani, M. et al. Oral human papillomavirus infection in HIV-infected and HIV-uninfected MSM: the OHMAR prospective cohort study. Sex. Transm. Infect. 96, 528–536 (2020).

Google Scholar 

Kreimer, A. R. et al. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet 382, 877–887 (2013).

PubMed Central  PubMed  Google Scholar 

Beachler, D. C. et al. Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults. Am. J. Epidemiol. 181, 40–53 (2015).

PubMed  Google Scholar 

Giuliano, A. R. et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 377, 932–940 (2011).

PubMed Central  PubMed  Google Scholar 

Nyitray, A. G. et al. Incidence, duration, persistence, and factors associated with high-risk anal human papillomavirus persistence among HIV-negative men who have sex with men: a multinational study. Clin. Infect. Dis. 62, 1367–1374 (2016).

PubMed Central  PubMed  Google Scholar 

Lu, B. et al. Human papillomavirus (HPV) 6, 11, 16, and 18 seroprevalence is associated with sexual practice and age: results from the multinational HPV Infection in Men Study (HIM Study). Cancer Epidemiol. Biomarkers Prev. 20, 990–1002 (2011).

PubMed Central  PubMed  Google Scholar 

Giuliano, A. R. et al. Seroconversion following anal and genital HPV infection in men: the HIM study. Papillomavirus Res. 1, 109–115 (2015).

PubMed Central  PubMed  Google Scholar 

Brown, D. R. et al. Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women. Tumour Virus Res. 13, 200236 (2022).

PubMed Central  PubMed  Google Scholar 

Brouwer, A. F., Eisenberg, M. C., Carey, T. E. & Meza, R. Trends in HPV cervical and seroprevalence and associations between oral and genital infection and serum antibodies in NHANES 2003–2012. BMC Infect. Dis. 15, 575 (2015).

PubMed Central  PubMed  Google Scholar 

Pamnani, S. J. et al. Impact of serum antibodies to HPV serotypes 6, 11, 16, and 18 to risks of subsequent genital HPV infections in men: the HIM study. Cancer Res. 76, 6066–6075 (2016).

CAS  PubMed Central  PubMed  Google Scholar 

Pierce Campbell, C. M. et al. Human Papillomavirus (HPV) L1 serum antibodies and the risk of subsequent oral HPV acquisition in men: the HIM study. J. Infect. Dis. 214, 45–48 (2016).

PubMed Central  PubMed  Google Scholar 

Pamnani, S. J. et al. Recurrence of genital infections with 9 human papillomavirus (HPV) vaccine types (6, 11, 16, 18, 31, 33, 45, 52, and 58) among men in the HPV Infection in Men (HIM) study. J. Infect. Dis. 218, 1219–1227 (2018).

PubMed Central  PubMed  Google Scholar 

Giuliano, A. R. et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N. Engl. J. Med. 364, 401–411 (2011).

CAS  PubMed Central  PubMed  Google Scholar 

Mehanna, H. et al. Human papillomavirus (HPV) vaccine effectiveness and potential herd immunity for reducing oncogenic oropharyngeal HPV-16 prevalence in the United Kingdom: a cross-sectional study. Clin. Infect. Dis. 69, 1296–1302 (2019).

CAS  PubMed  Google Scholar 

Chaturvedi, A. K. et al. Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the United States. J. Clin. Oncol. 36, 262–267 (2018).

CAS  PubMed  Google Scholar 

Damgacioglu, H. et al. Oropharyngeal cancer incidence and mortality trends in all 50 States in the US, 2001–2017. JAMA Otolaryngol. Head Neck Surg. 148, 155–165 (2022).

PubMed  Google Scholar 

Windon, M. J. et al. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults. Cancer. 124, 2993–2999 (2018).

CAS  PubMed  Google Scholar 

Burger, E. A. et al. Estimating the natural history of cervical carcinogenesis using simulation models: a CISNET comparative analysis. J. Natl Cancer Inst. 112, 955–963 (2020).

PubMed  Google Scholar 

de Sanjosé, S., Brotons, M. & Pavón, M. A. The natural history of human papillomavirus infection. Best Pract. Res. Clin. Obstet. Gynaecol. 47, 2–13 (2018).

Google Scholar 

Pierce Campbell, C. M. et al. Long-term persistence of oral human papillomavirus type 16: the HPV Infection In Men (HIM) study. Cancer Prev. Res. 8, 190–196 (2015).

CAS  Google Scholar 

Bettampadi, D. et al. Factors associated with persistence and clearance of high-risk oral human papillomavirus (HPV) among participants in the HPV Infection in Men (HIM) Study. Clin. Infect. Dis. 73, e3227–e3234 (2021).

Google Scholar 

Landy, R. et al. Upper age limits for US male human papillomavirus vaccination for oropharyngeal cancer prevention: a microsimulation-based modeling study. J. Natl Cancer. Inst. 115, 429–436 (2023).

PubMed Central  Google Scholar 

Burger, E. A., Kim, J. J., Sy, S. & Castle, P. E. Age of acquiring causal human papillomavirus (hpv) infections: leveraging simulation models to explore the natural history of HPV-induced cervical cancer. Clin. Infect. Dis. 65, 893–899 (2017).

PubMed Central  Google Scholar 

Chaturvedi, A. K. et al. NHANES 2009–2012 findings: association of sexual behaviors with higher prevalence of oral oncogenic human papillomavirus infections in U.S. men. Cancer Res. 75, 2468–2477 (2015).

CAS  PubMed Central  Google Scholar 

Oliver, S. E. et al. Risk factors for oral human papillomavirus infection among young men who have sex with men—2 Cities, United States, 2012–2014. Sex. Transm. Dis. 45, 660–665 (2018).

PubMed Central  Google Scholar 

Pickard, R. K. L., Xiao, W., Broutian, T. R., He, X. & Gillison, M. L. The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18–30 years. Sex. Transm. Dis. 39, 559–566 (2012).

Google Scholar 

Turati, F. et al. A meta-analysis of alcohol drinking and oral and pharyngeal cancers: results from subgroup analyses. Alcohol Alcohol. 48, 107–118 (2012).

Google Scholar 

Castañeda-Avila, M. A. et al. Sex and educational attainment differences in HPV knowledge and vaccination awareness among unvaccinated-sexually active adults in Puerto Rico. Hum. Vaccin. Immunother. 18, 2077065 (2022).

PubMed Central  Google Scholar 

Brondani, M. A., Siqueira, A. B. & Alves, C. M. C. Exploring lay public and dental professional knowledge around HPV transmission via oral sex and oral cancer development. BMC Public Health 19, 1529 (2019).

PubMed Central  PubMed  Google Scholar 

Strome, A., Moore-Petinak, N., Waselewski, M. & Chang, T. Youths’ knowledge and perceptions of health risks associated with unprotected oral sex. Ann. Fam. Med. 20, 72–76 (2022).

PubMed Central  Google Scholar 

Gesink, D., Salway, T., Kimura, L. & Connell, J. sexual health knowledge, attitudes, and perceptions among men who have sex with men during co-occurring sexually transmitted infection epidemics in Toronto, Canada: a qualitative study. Sex. Transm. Dis. 47, 658–662 (2020).

Google Scholar 

Dang, J., Feng, Q., Eaton, K. D., Jang, H. & Kiviat, N. B. Detection of HPV in oral rinse samples from OPSCC and non-OPSCC patients. BMC Oral Health 15, 126 (2015).

PubMed Central  Google Scholar 

Bettampadi, D. et al. Oral HPV prevalence assessment by linear array vs. SPF10 PCR-DEIA-LiPA25 system in the HPV Infection in Men (HIM) study. Papillomavirus Res. 9, 100199 (2020).

PubMed Central 

留言 (0)

沒有登入
gif